Fredric I. Orkin
Keine laufenden Positionen mehr
Profil
Fredric I.
Orkin served as a Director at Renal Solutions, Inc., Advanced Analytical Technologies, Inc., and HemoCleanse, Inc. Prior to that, he was a Vice President at Baxter International, Inc. from 1985 to 1992.
Orkin received his undergraduate degree from The Ohio State University in 1957.
Ehemalige bekannte Positionen von Fredric I. Orkin
Unternehmen | Position | Ende |
---|---|---|
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.1992 |
HemoCleanse, Inc.
HemoCleanse, Inc. Medical/Nursing ServicesHealth Services HemoCleanse, Inc. develops sorbent-based technologies to remove toxins from blood. It offers HemoCleanse-DT, a sorbent-based centrifuge-like device for liver dialysis and drug overdose detoxification applications; and HemoCleanse-PF, a sorbent-based centrifuge-like device for removing protein-bound toxins from plasma in applications, such as treatment of sepsis and autoimmuned diseases. The firm also provides AmSorb Ammonium sorbent for use in HemoCleanse; as an oral sorbent for urea control in the treatment of patients with renal insufficiency or end stage renal disease; and for ammonium removal in treatment of patients with chronic liver diseases. The company was founded by Stephen R. Ash and Robert B. Truitt in 1989 and is headquartered in Lafayette, IN. | Direktor/Vorstandsmitglied | - |
Advanced Analytical Technologies, Inc.
Advanced Analytical Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Analytical Technologies, Inc. manufactured rapid detection and enumeration systems for biomass organisms. The company was founded by Steven J. Lasky and Daniel Buttry in 1997 and was headquartered in Ankeny, IA. | Direktor/Vorstandsmitglied | - |
Renal Solutions, Inc.
Renal Solutions, Inc. Medical SpecialtiesHealth Technology Renal Solutions, Inc. develops, manufactures and distributes medical devices for dialysis. It commercializes the Allient Sorbent Hemodialysis Systems, a technology/service solution for the chronic and acute dialysis market. The company was founded by Peter M. DeComo on August 1, 2000 and is headquartered in Warrendale, PA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Fredric I. Orkin
The Ohio State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Renal Solutions, Inc.
Renal Solutions, Inc. Medical SpecialtiesHealth Technology Renal Solutions, Inc. develops, manufactures and distributes medical devices for dialysis. It commercializes the Allient Sorbent Hemodialysis Systems, a technology/service solution for the chronic and acute dialysis market. The company was founded by Peter M. DeComo on August 1, 2000 and is headquartered in Warrendale, PA. | Health Technology |
Advanced Analytical Technologies, Inc.
Advanced Analytical Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Analytical Technologies, Inc. manufactured rapid detection and enumeration systems for biomass organisms. The company was founded by Steven J. Lasky and Daniel Buttry in 1997 and was headquartered in Ankeny, IA. | Health Technology |
HemoCleanse, Inc.
HemoCleanse, Inc. Medical/Nursing ServicesHealth Services HemoCleanse, Inc. develops sorbent-based technologies to remove toxins from blood. It offers HemoCleanse-DT, a sorbent-based centrifuge-like device for liver dialysis and drug overdose detoxification applications; and HemoCleanse-PF, a sorbent-based centrifuge-like device for removing protein-bound toxins from plasma in applications, such as treatment of sepsis and autoimmuned diseases. The firm also provides AmSorb Ammonium sorbent for use in HemoCleanse; as an oral sorbent for urea control in the treatment of patients with renal insufficiency or end stage renal disease; and for ammonium removal in treatment of patients with chronic liver diseases. The company was founded by Stephen R. Ash and Robert B. Truitt in 1989 and is headquartered in Lafayette, IN. | Health Services |